Community Acquired Pneumonia
Download
Report
Transcript Community Acquired Pneumonia
Community-Acquired
Pneumonia
Nilesh Patel, D.O.
October 8, 2008
St. Joseph’s Regional Medical Center
Emergency Medicine Conference
Objectives
Epidemiology
Pathophysiology
Signs/Symptoms
Diagnostics
Treatments
Disposition
Questions we will answer…
What is the definition of CAP?
What are the most common organisms in CAP?
Do blood cultures affect management?
What is the optimal timing of antibiotic therapy in
CAP?
What are the antibiotic choices for CAP?
What are the admission criteria? Who can go
home?
Other
Next hour…
– Atypical pneumonias
– Viral pneumonias
– PCP/Other fungal pneumonias
What we will not talk about…
– Pediatric pneumonias
– HAP/HCAP
Community-Acquired
Pneumonia (CAP): Definition
Infection of pulmonary parenchyma
Pneumonia acquired in the community
– Excludes hospitals (HAP)
– Excludes extended care facilities (HCAP)
– Typical
– Atypical
Epidemiology
4 million cases/year in U.S.
600,000 - 1 million hospitalizations
12 cases per 1,000 adults/year
6th leading cause of death in U.S.
Leading cause of death due to infectious
cause
Mortality ranges from 1-20%
Mortality increased in certain populations
Pathophysiology
Aspiration of oropharyngeal organisms
Inhalation of infected aerosols
Hematogenous spread from extra-
pulmonary sites
Contiguous spread
Direct inoculation
Pathophysiology
Lobar pneumonia
Interstitial pneumonia
Bronchopneumonia
Multi-lobar pneumonia
Cavitary pneumonia
Necrotizing pneumonia
Lung Abscess
Pathophysiology
TYPICAL Organisms
– Streptococcus pneumoniae
– Haemophilus influenza
– Streptococcus pyogenes
– Klebsiella pneumoniae
– Moraxella catarrhalis
– Staph aureus
– Enterobacteriaceae/Gram negative bacilli
Anaerobic organisms (aspiration)
– Fusobacterium sp.
– Prevotella sp.
– Bacteroides sp.
Pathophysiology
ATYPICAL Organsims
– Mycoplasma pneumoniae
– Chlamydia pneumoniae
– Chlaymida sp.
– Legionella sp.
– Respiratory viruses
– Others
Pathophysiology
Strep pneumo
Strep pneumo
Gram positive lancet-shaped, encapsulated
diplococcus
“Most common cause of CAP”
Multiple serotypes
High mortality if untreated >> Sepsis
Strep pneumo
Signs/Symptoms
– Abrupt onset/ill appearance
– Cough (rust colored sputum)
– Fever/Chills
– Chest pain/SOB
– Tachypnea/Tachycardia
CXR
– Lobar infiltrate
– Bulging fissure
Treatments
– PCN
– Cephalosporin
Strep pneumo
H flu
H flu
Gram negative pleomorphic rods
Encapsulated/Unencapsulated forms
Serotypes a-f
“2nd most common cause of CAP”
Common pathogen in COPD patients
May also lead to sepsis
H flu
Signs/Symptoms
– Immunosuppresed/Debilitated patient
– Productive cough
– Fever
– Chest pain
– SOB
CXR
– Patchy alveolar infiltrates
Treatment
– Cephalosporins
– Augmentin
– Macrolide (Azithromycin)
H flu
H flu
H flu
Symptoms/Signs (Typicals)
Productive cough
Shortness of breath
Chest pain
Subjective fever/chills
N/V
Back pain
Abdominal pain
Abnormal VS
Rales/Rhonchi/Wheez
Decreased breath
sounds
Dullness to percussion
Increased tactile
fremitus
Bronchial breath
sounds
Egophany
Symptoms/Signs (Atypicals)
Dry Cough
+- Abnormal VS
Chest pain/SOB
Rales/Rhonchi/Wheez
Extra-pulmonary
symptoms;
Constitutional
symptoms
–
–
–
–
N/V/D
Headache
Myalgias
Fatigue
Symptoms/Signs
American Journal of EM 2006: 25, 631-36
– Retrospective, multi-center
– 421 patients diagnosed with CAP
– VS abnormalities were most significant
predictors of CAP
– Hypoxia had strongest association
– Greater # of VS abnormalities >> Higher
prevalence of CAP
– Age also significantly associated with CAP
Diagnostics
Labs
– CBC
– BMP
Imaging
– CXR
– CT scans
Cultures
– Blood
– Sputum
Other tests
– ABG/EKG
– Urine antigen tests
Diagnostics
IV
Oxygen
Monitor (pulse ox)
Diagnostics: WBC count
WBC count
– Normal count does not r/o pneumonia
– Elevated/Decreased >> Bacterial pneumonia
– Look for Left Shift!
Diagnostics: CXR
Findings
– Infiltrates
– Pleural effusions
– Abscess’/Cavities
– Bulging fissures
– Atelectasis
– Air bronchograms
Other findings
– PTX
– Pleural thickening/Scarring
– Pulmonary edema
– Lymphadenopathy/Masses
Diagnostics: CXR
Normal CXR
– Immunocompromised
– Dehydrated
– Early infection
American Journal of Medicine Sept. 2004: 117,
305-11
–
–
–
–
2706 patients
911 patients with pneumonia and (–)CXR
These patients were older, increased co-morbidities
These patients had similar rates of + sputum/blood
cultures
– These patients had a similar mortality
Diagnostics: CXR
Respiratory Medicine May 2006: 100, 926-
32
– 192 patients with pneumonia
– Excellent IR for lobes involved, extent of
infiltrate, pleural effusion
– Poor IR for pattern of infiltrate
– Minimal relation found between cultured
pathogens and radiologic features of infiltrate
on CXR
Diagnostics: CT scan
CT scan
– Alternative diagnoses
– Unresolved cases
– Complications suspected
– Concerning CXR
– Treatment failure
Diagnostics: Cultures
Sputum gram stain/culture
– Change antibiotic therapy
– Unusual pathogens/antibiotic resistance issues
– Do not change antibiotics/outcomes
– Cost
– Process issues
Sputum cultures?
– Are sputum cultures useful in ED?
– Are sputum cultures useful in ICU?
– Do antibiotics affect yield of sputum?
Diagnostics: Cultures
Sputum cultures: Recommendations
– Outpatient
• Optional
– Inpatient
• Optional
• Recommended when result may change therapy
– Recommended
•
•
•
•
•
•
•
ICU admission/Severe CAP
Failure of outpatient therapy
Cavitary infiltrates (suspect TB)
Alcoholism
Severe COPD
Pleural effusion
Positive urinary antigen for Legionella/Strep pneumo
Diagnostics: Cultures
Blood Cultures
– Yield pathogen 5-15%
– Blood cultures often do not change management
– Most commonly isolated organism…Strep pneumo
– High false positive rate
– Yield of blood cultures decreased by 50% by prior
antibiotic therapy
– Optional
– Recommended
•
•
•
•
Severe CAP
Immunodeficient states (asplenia, liver disease, HIV)
Indications for sputum cultures
Chest 2003
Diagnostics: Cultures
Blood Cultures
– Chest 2003: 123, 1142-1150
– Emergency Medicine Journal 2003: 20, 521-23
– Emergency Medicine Journal 2004: 21, 446-48
– Academic Emergency Medicine June 2006: 13,
740-45
– Journal of Emergency Medicine July 2007: 33,
1-8
Treatments
Supportive therapies
Antibiotics (outpatient/inpatient)
ICU therapies
Antibiotic resistance
Timing to antibiotics (6 hours)
Treatments
Annals of Emergency Medicine July 2001: 38,
107-113…”Clinical Policy for the Management
and Risk Stratification of CAP in Adults in the
Emergency Department”
– www.acep.org
Clinical Infectious Disease March 2007: 44, S27-
72…”Infectious Disease Society of America/ATS
Consensus Guidelines on the Management of
CAP”
Treatments: Basics/Supportive
ABCs
IV/Oxygen/Monitor
Albuterol nebulized
BIPAP
Intubation
IVF
Steroids
Treatments: Antibiotics
Empiric Antibiotics
– Based on most likely pathogen
– Local antimicrobial resistance patterns
– Antibiotics recommended by class
Pathogen specific Antibiotics
– Consider specific risk factors
Treatments: Antibiotics
Outpatient
Healthy patients
– MACROLIDE (Zithromax, Clarithromycin)
– DOXYCYCLINE
Co-morbid patients
– BETA LACTAM + MACROLIDE
– FLUOROQUINOLONE (Avelox, Levaquin)
Treatments: Antibiotics
Inpatient
FLUOROQUINOLONE (Levaquin,
Avelox)
BETA LACTAM + MACROLIDE
(Ceftriaxone/Cefotaxime + Zithromax)
Treatments: Antibiotics
Inpatient, ICU
BETA LACTAM (Ceftriaxone/
Cefotaxime/Unasyn) + Either MACROLIDE or
FLUOROQUINOLONE
PCN allergic: AZTREONAM +
FLUOROQUINOLONE
Pseudomonas
– ZOSYN, CEFEPIME, IMIPENEM, MEROPENEM +
FLUOROQUINOLONE OR MACROLIDE +
AMINOGLYCOSIDE
CA-MRSA
– Add VANCOMYCIN or LINEZOLID
Treatments: Antibiotics
Anaerobic coverage
– Not needed in majority of CAP cases
– Indications
•
•
•
•
•
Classic aspiration syndromes
LOC
Drug/ETOH overdose
Seizure
Hx of gingival disease/Esophageal dysmotility
– Antibiotics
• CLINDAMYCIN or FLAGYL
Treatments: Antibiotic
Resistance
Drug-resistant Strep pneumo (DRSP)
Community-acquired Methicillin resistant
Staph aureus (CA-MRSA)
Timing to Antibiotics
“Lots of Press”…JCAHO/CMS
JAMA 1997
– Decreased mortality in patients > 65 y/o antibiotics
within 8 hours
Archives of IM 2004
– Decreased mortality antibiotics within 4 hours
2008???
Timing to Antibiotics
Chest March 2007: 131, 1865-69
Annals of EM: May 2007: 49, 553-59
Annals of EM: May 2007: 49, 561-63
Clinical Infectious Disease March 2007: 44, S27-
72
– “Do not recommend a specific time window for
delivery of first antibiotic dose”
ACEP News July 2007…”Studies Challenge 4-
Hour Antibiotic Guideline for CAP”
Timing to Antibiotics
Physician…Antibiotics should be
administered as soon as possible once CAP
is diagnosed/considered likely
JCAHO…Antibiotics within 6 hours for
CAP
Disposition
WHO STAYS…WHO CAN WE
DISCHARGE???
NEJM January 1997: 336, 243-50
– PORT cohort study
– Prediction rule derived in 14,000 patients
– Prediction rule validated in 40,000 patients
– Predicts patients with increased 30 day mortality
– Helps ER physicians with admission/discharge
decisions
– PNEUMONIA SEVERITY INDEX (PSI)
Disposition
CURB-65 criteria (British Thoracic
Society)….1,068 patients
–
–
–
–
–
Confusion
Uremia
Respiratory rate
Blood pressure (low)
> 65 y/o
CAP 2008
Epidemiology of CAP has remained stable
Typicals and atypicals—the lines are
blurred
Patient risk factors
Diagnostics
–
–
–
–
WBC count
Sputum cultures
Blood cultures
Urine antigen tests
CAP 2008
Treatment
–
–
–
–
Outpatient (healthy, co-morbid)
Inpatient
Inpatient (ICU, risk factors)
HAP, HCAP (ask the ?’s)
ED treatment considerations
– Empiric coverage
– Blood cultures prior to antibiotic therapy
– Antibiotics in 6 hours
Drug resistance
– DRSP, CA-MRSA
Summary
Epidemiology
– Common problem
Pathophysiology
– Strep pneumo most common
– Typicals/Atypicals
Signs/Symptoms
– Cough (productive, nonproductive)
– SOB/cp
– Fever
– Abnormal VS
– Abnormal lung exam
Summary
Diagnostics
– CXR with infiltrate
– Sputum GS/cultures
– Blood cultures
Treatments
– ABC
– IV/O2/Monitor
– Antibiotics
Disposition
– PSI, Curb-65 criteria